{"nct_id":"NCT01313689","title":"Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia","status":"COMPLETED","status_verified_date":"2018-10","start_date":"2011-04-14","start_date_type":"ACTUAL","primary_completion_date":"2014-03-18","primary_completion_date_type":"ACTUAL","completion_date":"2017-04-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}